Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches
Current epidemics, such as HIV or influenza, and the emergence of new threatening pathogens, such as the one causing the current coronavirus disease 2019 (COVID-19) pandemic, represent major global health challenges. While vaccination is an important part of the arsenal to counter the spread of vir...
Enregistré dans:
Auteurs principaux: | Merve Cakir, Kirsten Obernier, Antoine Forget, Nevan J. Krogan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/85a6dbc912814a749a2a574b6f58a119 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
par: Xiaonan Liu, et autres
Publié: (2021) -
The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
par: Irina RUSU, et autres
Publié: (2020) -
Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer
par: Carolina Moretto Carnielli, et autres
Publié: (2018) -
Antiviral Drug Discovery To Address the COVID-19 Pandemic
par: Douglas D. Richman
Publié: (2020) -
A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases
par: Zhizhen Li, et autres
Publié: (2021)